What a great opportunity to start establishing a position at this price with some decent catalysts to come in the next few months
- Forums
- ASX - By Stock
- ATX
- Ann: Type D Meeting Outcome With US Food And Drug Administration
ATX
amplia therapeutics limited
Add to My Watchlist
11.4%
!
19.5¢

Ann: Type D Meeting Outcome With US Food And Drug Administration, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
19.5¢ |
Change
0.020(11.4%) |
Mkt cap ! $75.65M |
Open | High | Low | Value | Volume |
16.5¢ | 20.0¢ | 16.5¢ | $962.1K | 5.280M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 202615 | 19.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 339872 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 202615 | 0.190 |
3 | 103173 | 0.185 |
6 | 252773 | 0.180 |
6 | 181118 | 0.175 |
3 | 227785 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 339872 | 7 |
0.205 | 255000 | 2 |
0.210 | 200852 | 4 |
0.215 | 120000 | 3 |
0.220 | 276500 | 3 |
Last trade - 16.11pm 26/06/2025 (20 minute delay) ? |
Featured News
ATX (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online